Melanoma News and Research

Latest Melanoma News and Research

Top 12 health issues facing Australian children

Alarming levels of poorer health within indigenous children and those from lower socio-economic backgrounds tops a new list of 12 major issues threatening the future health of Australia.

10 Oct 2005

Important milestone towards more individually targeted and effective treatments for cancer patients

The research team has now identified crucial genes in a range of common cancers that have been reported to predict a patient's response to treatment. This follows the team's earlier success in studying a tumor suppressor gene associated with acute lymphoblastic leukaemia (ALL) in children.

9 Oct 2005

Melanoma patients with a positive family history and/or dysplastic nevi were found to be at higher risk for multiple primary melanomas

Memorial Sloan-Kettering Cancer Center (MSKCC) researchers have found that melanoma patients with a family history of melanoma and/or dysplastic nevi (abnormal moles) are at high risk of developing multiple primary melanomas (MPM). Researchers recommend more intensive follow up for these high-risk patients.

9 Oct 2005

Cancer incidence among women has increased slightly

Overall rates of cancer death for both men and women have declined in the United States, and cancer incidence has remained stable among men. However, overall cancer incidence among women has increased slightly, according to a special article that appears in the October 5 issue of the Journal of the National Cancer Institute.

4 Oct 2005

Americans' risk of dying from cancer continues to decline

The nation's leading cancer organizations report that Americans' risk of dying from cancer continues to decline and that the rate of new cancers is holding steady. The "Annual Report to the Nation on the Status of Cancer, 1975-2002," published in the Oct. 5, 2005, issue of the Journal of the National Cancer Institute, shows observed cancer death rates from all cancers combined dropped 1.1 percent per year from 1993 to 2002.

4 Oct 2005

Patients with a family history of multiple melanoma skin cancer are at increased risk of multiple primary melanomas

In 2005, there will be an estimated 62,000 new cases of invasive melanoma and an estimated 7,600 deaths due to melanoma in the United States, according to background information in the article. Melanoma is the fifth leading cancer in men and the sixth leading cancer in women in the United States.

4 Oct 2005

People who receive a kidney transplant are nearly four times more likely to develop melanoma

...a rare but deadly form of skin cancer, according to a study led by Christopher Hollenbeak, Ph.D., associate professor, Departments of Surgery and Health Evaluation Sciences, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center.

28 Sep 2005

A new, less toxic way to treat malignant melanoma

A new, less toxic way to treat malignant melanoma (skin cancer) is being developed by medicinal chemists at Reading University. They have produced a range of prodrugs: compounds that offer the potential to be converted to toxic molecules only within the vicinity of tumours. These prodrugs aim to reduce the toxicity of treatment.

26 Sep 2005

Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells

The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies.

26 Sep 2005

New technique may provide a better way of monitoring response to melanoma treatment

A new study published in PLoS Medicine describes a way to measure the immune response in people treated with an experimental vaccine to melanoma.

26 Sep 2005

People who receive a kidney transplant are nearly four times more likely to develop melanoma

...a rare but deadly form of skin cancer, according to a study in the November 1, 2005 issue of Cancer, a peer-reviewed journal of the American Cancer Society.

26 Sep 2005

Next generation of effective viral-based therapies for cancer

Researchers at Columbia University Medical Center continue to make strides in their work to develop the next generation of effective viral-based therapies for cancer.

21 Sep 2005

Workshop - stem cells in reproduction and in the brain

"Once we have found the factors by which body cells can be re-programmed into stem cells, then therapeutic cloning might become superfluous," said Hans R. Scholer, director of the Max Planck Institute for Molecular Biomedicine in Munster, Germany, at an international scientific symposium on stem cell research in Kobe, Japan.

10 Sep 2005

Researchers discover one of the reasons why melanoma is so ruthless

About 60,000 Americans will be diagnosed with melanoma this year, says the American Cancer Society, and 10,000 of those cases will be fatal. If not caught in the early stages, melanoma can be a particularly virulent form of cancer, spreading through the body with an efficiency that few tumors possess.

5 Sep 2005

Carbohydrate known as OGT2378 inhibits tumor growth

A non-toxic chemical compound that prevents cancer cells from producing a critical membrane component has been shown to suppress tumor growth and tumor size in mice without unwanted side effects, according to researchers at the Children’s National Medical Center in Washington, D.C.

30 Aug 2005

Before hitting the beach, learn the signs of skin cancer

With summer coming to a close, the American Society for Therapeutic Radiology and Oncology has published a new brochure to help the public understand the signs and symptoms of skin cancer as well as learn the treatment options for the disease.

29 Aug 2005

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.

25 Aug 2005

Melanoma News and Research

Latest Melanoma News and Research

Top 12 health issues facing Australian children

Important milestone towards more individually targeted and effective treatments for cancer patients

Melanoma patients with a positive family history and/or dysplastic nevi were found to be at higher risk for multiple primary melanomas

Cancer incidence among women has increased slightly

Americans' risk of dying from cancer continues to decline

Patients with a family history of multiple melanoma skin cancer are at increased risk of multiple primary melanomas

People who receive a kidney transplant are nearly four times more likely to develop melanoma

A new, less toxic way to treat malignant melanoma

Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells

New technique may provide a better way of monitoring response to melanoma treatment

People who receive a kidney transplant are nearly four times more likely to develop melanoma

Next generation of effective viral-based therapies for cancer

Workshop - stem cells in reproduction and in the brain

Researchers discover one of the reasons why melanoma is so ruthless

Carbohydrate known as OGT2378 inhibits tumor growth

Before hitting the beach, learn the signs of skin cancer

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

Higher protection sunscreens do not encourage people to spend more time in the sun

Thousands of young athletes at risk of skin cancer

Young athletes at high risk for developing skin cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Melanoma News and Research

Latest Melanoma News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in